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Abstract 
Accurate prediction of oral absorption of drugs relies on biorelevant methodology. Current 
methods are based on Western healthy adult populations. Malnourished children have many 
differences in their gastrointestinal anatomy and physiology compared to a healthy Western 
adult. These differences may affect the oral absorption of medicines and it is important to 
gather knowledge on these GI differences in order to develop biorelevant predictive methods 
for this vulnerable population.  
A literature search was conducted within PubMed and Scopus to identify papers that describe 
how gastrointestinal physiology and anatomy is altered in malnourished children. Relevant 
data was extracted and a narrative review generated to describe how GI differences may affect 
oral drug absorption. 
Several differences in GI anatomy and physiology were reported in the literature including: 
reduced saliva secretion; increased gastric pH; slower gastric emptying; increased levels of 
bacteria in the small intestine; reduced surface area of intestinal villi and increased intestinal 
permeability. Much of the data was more than 30 years old and referred to a heterogeneous 
malnourished population.  
Sufficient data has been identified that will inform basic novel biorelevant methods to predict 
oral drug absorption in malnourished children. Further work is required to generate additional 
data to improve these models and also to verify the models with appropriate pharmacokinetic 
data. 
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1 Introduction 
When administering an oral drug product to a patient there are various factors which are 
important to ensure sufficient drug absorption; these include drug- and formulation-related 
parameters like drug solubility and permeability, drug product dissolution and gastrointestinal 
(GI) conditions including the composition and physicochemical properties of GI fluids, transit 
time and gut wall conditions relevant to metabolism, passive diffusion and active transport of 
drugs. GI physiology is therefore a key aspect that determines the in vivo performance of orally 
administered drugs.  
Over the last decades, bio-predictive in vitro models have been established for predicting oral 
drug exposure for a number of compounds in adults after dosing either in fasted or fed 
conditions. There is a lack of such in vitro models for children, yet they are urgently required 
to better predict the in vivo performance of medicines in children to minimize the burden of 
clinical testing. When developing biorelevant in vitro media and models to simulate 
gastrointestinal conditions, the most appropriate environment needs to be represented. It is 
already known that there are differences in the gastrointestinal physiology of children in 
different age groups and in comparison to adults, which are accompanied by variable volumes, 
pH values and composition [1]; it is obvious that these differences will be different again in 
children suffering from diseases affecting GI conditions or in malnourished children.  
Malnutrition is a condition that is reported for several patients groups and can be quite 
common in hospitalized and elderly patients [2-4], pregnant and breastfeeding women, and 
children [5]. Due to their high nutritional requirements children are more susceptible to 
malnutrition than adults [6]. When designing appropriate bio-predictive in vitro models, it will 
be essential to consider the specific GI features of malnourished children. To date, a review 
of the GI conditions in malnourished children is not available. However, it is obvious, that 
malnutrition will alter the GI environment. An altered GI environment may affect 
pharmacokinetics of orally administered drugs, which in turn may affect efficacy and 
subsequent therapy. In basic terms the absorbable dose is influenced by the transit time; 
concentration of drug at the absorbing surface; surface area available for absorption and the 
permeability of the drug across the membrane. Differences in any of these parameters will 
affect the fraction of dose absorbed; hence predictions made in a healthy population may be 
very different to those where the GI parameters are different. A detailed understanding of the 
nature of specific GI parameters in malnourished children and of how much they may affect 
timing, site and extent of in vivo drug release seems to be one of the key factors for developing 
better oral medications for these children. Moreover, any in vitro and/or in silico models that 
consider these relevant GI parameters and would be applicable to predict the in vivo 
performance of orally administered drugs in malnourished children would be extremely 
beneficial with regard to increasing the safety and efficacy of oral medicines provided to this 
patient group. 
The group of malnourished patients describes a heterogenous population. Malnutrition refers 
to deficiencies, excesses or imbalances in a person’s intake of energy and/or nutrients. 
Malnutrition is divided into undernutriton, which includes stunting, wasting and underweight, 
and to overweight, which includes obesity and several diet relevant diseases as heart disease 
and cancer [7]. Undernutrition is caused by a lack of food in general, but also by inadequate, 
unhealthy diets and diseases including digestive and absorptive disorders resulting in 
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micronutrient deficiencies. It makes children in particular much more vulnerable to disease 
and death and is responsible for approximately 50 % of child mortality for those under five 
years old [8]. According to the latest United Nations International Children’s Emergency Fund 
(UNICEF) / World Health Organisation (WHO) / World Bank Group Joint Child Malnutrition 
Estimates (May 2018) at least 202 million children worldwide are stunted or wasted [8]. 
In the literature, different criteria that have been applied to classify the nutritional status of 
children can be found (Table 1). According to current WHO criteria undernutrition can be 
present in 4 broad sub-forms, i.e. underweight (low weight-for-age), stunting (low height-for-
age), wasting (low weight-for-height) and deficiencies in vitamins and minerals [7]. 
The main hallmark of child malnutrition is growth retardation. Underweight, which represents 
low weight for age [7], is defined as a weight-for-age at least two standard deviations below 
the median weight based on the WHO child growth standards [9, 10]. “Stunting” is a term for 
chronic undernutrition and reflects low height for age [7]; defined as less than two standard 
deviations (SD) below the WHO standards [9, 10]. Acute undernutrition is termed “wasting”, 
where moderate wasting is indicated by a weight between two and three SDs below the WHO 
standards [9, 10]. Severely wasted children have a weight of less than three SDs below the 
WHO standards or a mid-upper arm circumference (MUAC) of less than 115 mm in children 
of 6-60 months [9-11]. 
“Severe wasting” and bilateral oedema are independent diagnostic criteria for severe acute 
malnutrition (SAM), which is associated with a high risk of death and which requires urgent 
therapeutic feeding [11].  
Protein-calorie malnutrition (PCM) is a specific subtype of SAM with a deficiency in 
macronutrients including protein, carbohydrates and fat. The WHO defines PCM, also known 
as protein energy malnutrition (PEM), as "a pathological condition that results from a lower 
ingestion of protein and calories, which occurs more frequently in children under five years of 
age". Severe PCM can be categorized into three principal clinical forms: (i) marasmus, an 
acute malnutrition characterized by severe wasting of fat and muscle and a gross underweight 
status; (ii) kwashiorkor presents with moderate growth retardation and bilateral pitting 
oedema; and (iii) marasmic kwashiorkor, the most severe form of PCM, a mixed form of both 
marasmus and kwashiorkor that is characterized by the presence of both wasting and bilateral 
pitting oedema [12].  
PCM is a major public health problem affecting a high proportion of infants and older children 
world-wide and accounts for a high childhood morbidity and mortality in the developing 
countries. Its association with a wide spectrum of infections necessitates multiple drug 
therapies. Whereas the epidemiology of PCM has been extensively studied globally, the 
pathophysiological changes that may affect disposition of these drugs in malnourished 
children have not been reviewed in that much detail [13]. Oshikoya et al. [14] performed a 
systematic literature review to determine the effects of PCM on drug pharmacokinetics and 
concluded that there have been relatively few pharmacokinetic studies of drugs frequently 
used for treatment of children with PCM. However, they also present case examples in which 
decreased absorption of drugs such as carbamazepine [15], chloroquine [16], sulphadiazine 
[17], and chloramphenicol [18] have been reported in children with PCM when compared with 
healthy normal children and was attributed to morphological changes in the jejunum. In 
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addition, treatment failure with artemether-lumefantrine was reported to be due to incomplete 
absorption in a malnourished child [19]. 
The aim of this review was to review the available data on the gastrointestinal anatomy and 
physiology of malnourished children relevant to the performance of orally administered 
medicines. The focus was set on the screening of the particular features of undernutrition. 
Thus, in the following sections, the terms malnutrition and undernutrition can be regarded as 
interchangeable. 
 
TABLE 1 HERE PLEASE 
 
2 Materials and methods 
A literature search was conducted within PubMed and Scopus using the search terms listed 
in Figure 1. 
 
FIGURE 1 HERE PLEASE 
 
Literature that provided original data on parameters that affect GI physiology associated with 
oral administration and absorption of drugs were included in further analysis. Specifically 
literature that reported aspects on gastrointestinal transport, motility or contents was sought. 
Studies where children had co-morbidities were also included in the analysis.  
The search was conducted between September 2017 and March 2018. The search results 
were sorted by the authors (LF and EP-S) based on titles, abstracts or full text articles. 
Additional literature was obtained from reference lists of the identified articles or reviews on 
this topic.  
For data extraction, studies were sorted according to whether they investigated oral cavity, 
gastric, small intestinal or large intestinal parameters. Further sorting permitted papers to be 
reviewed based on physiological parameters of these regions. Data was extracted from 
relevant papers to gather evidence that was summarized for each absorption parameter. 
There was too much heterogeneity in the identified literature which did not permit a systematic 
meta-analysis. Therefore the results could not be presented as a systematic review. Thus, a 
narrative review was selected to discuss reported effects of malnutrition that would impact on 
oral drug absorption considering the process from the initiation of oral ingestion to excretion. 
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3 Results 
Definition of malnutrition used in the papers identified. 
The wide range of criteria used to classify malnutrition was highlighted in Table 1 and the 
papers identified used a range of these criteria when reporting results. The NCHS criteria were 
the most commonly used with the Gomez index, the Wellcome classification and WHO child 
growth standards being used in multiple studies [23, 26-43]. 
 
3.1 Oral cavity 
The oral cavity is the site of administration for oral medicines. Solid oral dosage forms are 
usually designed to be swallowed whole and to release the drug in the stomach and/or 
intestine. However, in children solid oral dosage forms might not be swallowed as rapidly as 
in adults. Thus, there is a chance that conditions in the oral cavity such as pH, buffer capacity 
and composition of saliva affect both integrity and drug release from solid oral dosage forms 
and consequently affect in vivo drug release. Dosage form integrity could be affected by 
mechanical forces caused by tongue and palate as well as by the volume, pH, buffer capacity 
and composition of saliva. Salivary pH and buffer capacity also play an important role in dental 
diseases and compared to healthy children a higher incidence of caries and other dental 
diseases have been observed in children with poverty driven malnutrition [44, 45]. Increased 
residence time and drug release in the oral cavity can increase systemic drug absorption 
across the oral mucosa. Therefore, mucosal integrity is also an important fact to consider 
when discussing drug administration to malnourished children. 
3.1.1 Salivary secretion 
Salivary secretion has been reported to be lower in malnourished compared to healthy children 
(Table 2a). Agarwal et al. reported that saliva collection took longer (30-40 minutes) following 
stimulation with citric acid and strawberry flavor in malnourished children compared to control 
children or children (aged 1-10 years) with milder forms of PEM (10 min) [30]. Other research 
found impaired saliva flow rates in severely malnourished children (aged 8-12 years and 11-
19 years) in both unstimulated and stimulated conditions [32, 35]. Saliva flow rates were 
reported to be linked with level of malnutrition and the reduction in flow rate was related to the 
severity of PEM [35]. However, it should be noted, that malnutrition is often linked with 
dehydration which independently of malnutrition is known to affect saliva secretion rate [46, 
47]. 
3.1.2 Saliva pH and buffer capacity 
The pH of saliva was reported to be lower (6.9 ± 1.85) in underweight children compared to 
children of a normal weight (8.1 ± 1.95) (aged 6-12 years) [45] (Table 2b). In addition a 
reduction in salivary buffer capacity has been reported for this patient group [23, 32, 45]. 
3.1.3 Saliva composition  
Concentrations of sodium, potassium, phosphate, hexosamines, fucose, sialic acid and total 
protein as well as amylase activity in malnourished children have been reported to be similar 
to those of a control group (aged 8-12 years) [23] (Table 2c).  However, in the malnourished 
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group (aged 8-12 years) significantly lower concentrations of calcium and chloride as well as 
a decreased amount of protein secreted per minute were found in paraffin-stimulated whole 
saliva [23]. Agarwal et al. detected a continuous fall of protein, ferritin and arginase activity in 
stimulated saliva that correlated with the severity of PEM [30].  
Analyses of unstimulated whole saliva show contradictory results regarding the concentrations 
of total IgA: while Johansson et al. detected no differences in the concentrations of total IgA 
between the PEM group and the control group; McMurray et al. found reduced IgA 
concentrations in malnourished children (aged 1.5-2 years) [23, 31]. Salivary total protein, 
albumin and aminopeptidase were found in similar concentrations in all children by McMurray 
et al. and, Johansson et al. detected lower concentrations of anti-S. mutans IgA and lactoferrin 
as well as lower activity of the bacteria agglutinating protein (BAGP) in the PEM group.  
3.1.4 Oral mucosa integrity 
PEM appears to have multiple effects on the oral tissues and oral disease development [35]. 
Besides deficiencies in protein malnourished children PEM results in a lack of a number of 
essential vitamins and minerals that effect structures in the oral cavity. These include folate 
and other B complex vitamins; vitamins A, C, and D, calcium and fluoride. Consequently, 
besides impaired dentition, the nutritional status of the body is also associated with 
disturbances in other oral structures and presents with recurrent aphthous stomatitis, atrophic 
glossitis, painful, burning tongue characterized by inflammation and defoliation of the tongue, 
mucosal atrophy and oral ulcers [35, 48, 49]. There is very little data reported on the extent to 
which oral mucosa integrity is impaired in malnourished children. However, there is evidence 
that long-term chronic malnutrition causes a significant reduction in resistance and 
progressive damage to the oral mucosa that will result in reduced resistance to colonization 
and invasion of pathogenic microorganisms [50] and consequently will most probably also 
enhance permeability and therefore oromucosal drug absorption. 
In summary, the imbalance between the supply of the nutrients and the body’s demand results 
in several oral manifestations that could alter oral drug absorption. However, whereas the 
impacts on dentition are usually irreversible, in children rehabilitation will most likely result in 
complete recovery of oral mucosa integrity, saliva secretion and composition. 
 
TABLES 2 AND 3 HERE PLEASE 
 
3.2  Stomach 
Volume, composition and physicochemical properties of gastric fluids are important factors 
regarding drug solubility and/or disintegration properties of solid oral dosage forms and thus 
can affect in vivo drug release. The motility pattern in the stomach and the secretion of gastric 
juices are directly dependent on food intake. Thus, it is necessary to differentiate between the 
fasted and fed state. Different nutrition habits or long periods of fasting lead to the assumption 
that gastric conditions in malnourished children may differ from conditions in healthy children, 
which may result in altered drug performance. 
3.2.1 Gastric contents 
Several studies have shown correlations between reduced fasted gastric acid secretion and 
malnutrition (Table 3a). Gracey et al. detected, that unstimulated gastric acid secretion was 
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reduced in 9 of 14 malnourished children, while maximal acid output (60 minutes after 
pentagastrin stimulation) was below normal in all malnourished patients (aged 7-54 months) 
[42]. Gilman et al. reported that the fasted gastric acid output was lower in severely 
malnourished Bangladeshi children compared to better nourished children (0.22 vs 0.52 mEq 
HCl/h) (aged 3.3 ± 2.4 years) [38]. In the children enrolled in the Gilman study, three weeks of 
nutritional rehabilitation lead to equivalent rates of fasted gastric acid secretion in the two 
groups showing that this is a reversible phenomenon [38]. At this point, it also should be noted 
that as for saliva secretion, impaired gastric secretion may relate to both malnutrition or 
dehydration of the children, which often cannot be clearly distinguished. Thus, the increase in 
gastric acid secretion could be also an effect of rehydration. Shashidhar et al. detected a 
decreased mean acid concentration in malnourished children (aged 12-60 months), here 
divided into kwashiorkor and marasmic children, under unstimulated and stimulated fasted 
conditions, although results show a high interindividual variability [51].  
Under unstimulated fasted conditions the pH of gastric juice was above 4 in 76 % of 
malnourished children; After nutritional rehabilitation this decreased to 69 % in malnourished 
children compared to 55 % in better-nourished children (aged 3.3 ± 2.4 years) [38]. Under 
stimulated conditions, the percentage of pH values above 4 was reduced: 26 % in 
malnourished children, 24 % in children after nutritional therapy and 0 % in better-nourished 
children [38]. However, pH of gastric juice under stimulated fasted conditions is not equal to 
gastric pH under fed conditions. Thus, also the composition and quantity of food has an 
important impact on gastric pH, especially when considering that there are various types of 
diets worldwide. 
Peptic activity was reported to be significantly reduced in malnourished children under fasted 
conditions compared to well-nourished children (aged 12-60 months) [51] (Table 3a). Yet, 
shortly after stimulation of gastric secretion peptic activity rose in all children although it was 
still significantly decreased in malnourished children.  
The reduced gastric output observed at baseline in severely malnourished children correlates 
to a higher incidence of infections [53] credited to the loss of the gastric acid barrier. The 
relationship between H. pylori infection and acidity within the stomach is complex; a low level 
of acidity in the stomach may increase the risk of infection in the gastrointestinal tract and also 
overgrowth of intestinal bacteria that may lead to diarrhoea. The prevalence of H. pylori in 
children is high in developing countries and since H. pylori infection is associated with an 
increased gastric pH, it might be associated with malnutrition [38, 54, 55].  
In conclusion, available literature reports reduced gastric acid secretion in malnourished 
children, yet nutritional rehabilitation seems to result in an immediate improvement. It should 
be noted that nutritional rehabilitation typically results in rehydration of malnourished children. 
Malnourished children with watery diarrhea are usually treated with Rehydration Solution for 
Malnutrition (ReSoMal) [56]. Hence the increase in gastric acid secretion can be caused by 
both nutritional rehabilitation and rehydration. 
  
9 
 
3.2.2 Gastric emptying 
Investigations on gastric emptying in malnourished children show contradictory results (Table 
3b). Brunser et al. (within a review paper) stated without indicating a reference, that there are 
clinical observations showing that severe cases of malnutrition are characterized by gastric 
dilatation, slow emptying and vomiting [52]. Two studies investigating gastric emptying in 
marasmic, kwashiorkor and marasmic kwashiorkor children (aged 5-29 months and 7-45 
months) showed that children with marasmus showed faster gastric emptying of a 5 % (w/v) 
glucose solution administered at a volume of 20 mL/kg body weight compared to a control 
group. Severely malnourished children with kwashiorkor had no detectable abnormalities in 
gastric emptying, while in marasmic kwashiorkor children a tendency of delayed gastric 
emptying was observed [33, 34]. However, the power of these studies is limited, as the patient 
group was treated with different helminthics such as thiabendazole, which can evoke 
unspecific gastrointestinal disorders. In contrast, a significantly delayed gastric emptying in 
both marasmic and marasmic kwashiorkor children (aged 11.97 ± 6.03 months) was reported 
by Shaaban et al. [41]. In an ultrasonographic study they investigated the impact of nutritional 
rehabilitation on gastric emptying using a liquid (infant powdered milk formula) and a semisolid 
meal (milk, rice and high protein additive). They found a clear delay in gastric emptying of both 
liquid and semisolid food in marasmic and marasmic kwashiorkor children when compared to 
a control group (aged 11.97 ± 6.03 months). As could be expected, the delay in the gastric 
half emptying time was higher with the semisolid than with the liquid meals [41]. Nutritional 
rehabilitation was observed to speed up gastric emptying after 30 ± 7 days of nutritional 
treatment [41]. 
 
3.3 Small intestine 
The small intestine is the site where maximal drug absorption occurs. Therefore, small 
intestinal conditions, such as luminal contents, surface area, transit time and mucosal 
permeability, can affect drug absorption and this information can help to develop predictive in 
vitro test designs as accurately as possible. 
3.3.1 Small intestinal contents 
The small intestinal contents influence the solubility of drugs which in turn will influence their 
absorption. Key components of small intestinal fluids are bile, enzymes and bacteria. 
Mehta et al. analyzed the duodenal contents following a milk stimulus from sixty marasmic 
children between the ages of 9-42 months. Results showed significantly lower mean 
concentrations of conjugated bile acids (1.36 mg/mL vs. 2.92 mg/mL) and total bile acids in 
marasmic children compared to well-nourished children, while the concentration of free bile 
acids was increased (0.60 mg/mL vs. 0.06 mg/mL) (Table 4a). Unfortunately, measured pH 
values weren’t published, but the low pH of duodenal juice was mentioned [43]. Duodenal 
aspirates were analyzed from 18 severely protein calorie malnourished children (aged 15-64 
months) to measure the contents with respect to the ability to achieve micellar solubilisation 
of lipids. The results showed that micellar lipid and fat absorption were low in PCM children 
due to lower levels of bile salts [57]. Children under 5 years of age with severe acute 
malnutrition were shown to have higher total serum bile acids compared to controls which 
relates to lower biliary secretion within the GI tract [58]. 
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Sauniere et al. analyzed the duodenal contents of 25 children (1 month to 8 years) with acute 
symptoms of kwashiorkor. Bicarbonate and volume of duodenal juice of malnourished children 
were not different compared to the normal African population, while pancreatic enzymes, such 
as amylase and lipase, were significantly decreased, except for trypsin, which was not affected 
[59]. These results agree with the findings from 40 children (aged 9-51 months) with 
kwashiorkor where a wide variation in significant depression of enzyme activity was observed 
[60] (Table 4b). 
Underproduction of acid in the stomach is the most likely cause of the bacterial overgrowth 
observed in the small intestine of undernourished children. The impact of high levels of 
bacteria in the small intestine include impaired nutrient absorption and risks of sub-efficacious 
oral vaccination in children aged 2 months to 5 years [61]. Several studies have reported 
higher than usual levels of viable bacteria within the small intestine in malnourished children 
(aged 9 months to 6 years) [62, 63] (Table 4c).   
3.3.2 Intestinal fluid output and dehydration in malnutrition 
The adult small intestine receives large quantities of fluid via dietary fluid intake or as 
secretions from salivary glands, stomach, pancreas, liver and the small intestine itself. The 
small intestinal epithelium absorbs about 6-7 L of fluid per day. Only about 1.5 L enter the 
large intestine and are further reduced to less than 250 mL/day that are excreted with feces. 
If an individual has diarrhoea then osmoregulation is affected and the fluid within the intestine 
is not reabsorbed and the total intestinal fluid output is elevated to balance the osmolality to 
favour the absorption [64]. The small intestine is typically a site of net water absorption which 
has been observed in children with malnutrition. However, in cases of malnutrition that is 
associated with diarrhoea a net secretion of water was measured within the jejunum [65]. This 
alteration from net absorption to net secretion is likely to reduce the uptake of drugs within the 
GI tract in cases of diarrhoea. 
 
TABLE 4 HERE PLEASE 
 
3.3.3 Intestinal permeability 
Several studies done in the 1960-1970s showed that the shape of the small intestinal wall 
changed from regular long villi in healthy patients (villi are structures within the small intestine 
that increase the small intestinal surface area and, consequently, absorption) to irregular 
broader and shorter villi in malnourished children (0-3 years) and that the shape in malnutrition 
is associated with an overall smaller surface area compared to healthy tissue [67, 70, 76] 
(Table 4e). However, increased permeation of cellular materials was seen suggesting that the 
intestine is more permeable in malnutrition [67, 70, 76]. As the severity of malnutrition 
increases so do the changes in the intestinal epithelium as the abnormalities in marasmus 
were mild in comparison to children (aged 0-3 years) with kwashiorkor [76]. Atrophy of villi in 
malnutrition has also been reported [68-70]. 
The Lactulose/Mannitol intestinal permeability test (L:M) is a commonly used technique to 
measure small intestinal function and can relate to changes in: a) small intestinal epithelial 
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area; b) transcellular and paracellular transport and c) damage and permeability. Mannitol can 
be used as a marker to assess the mucosal absorptive area and lactulose to assess the 
integrity of the intestinal membrane. In some studies a lactulose/rhamnose test is used; 
rhamnose is similar to mannitol in that it is a monosaccharide and mucosal damage will reduce 
mannitol/rhamnose absorption whilst increasing permeability of lactulose.  
A typical reference value for L:M is 0.09 as this was defined as an upper normal limit in 30 
healthy Dutch children (aged 0-16 years) [77]; values greater than 0.09 suggest enteropathy 
is present. Typically, lactulose (which is large) relates to the overall integrity of the membrane 
and mannitol can relate to the surface area or overall absorptive capacity of the membrane.  
A study on 97 severely underweight Bangladeshi children (mean age 9 years) showed that 
the difference in mannitol absorption was greater than in lactulose absorption in malnourished 
children compared to healthy children; this relates to the loss of surface area which is 
consistent with the shape changes in the villi [27]. Intestinal biopsy studies [70, 78] in 
malnourished children show that kwashiorkor is associated with villous atrophy, decreased 
villous-crypt ratio and increased cellularity of the lamina propia; these changes impact the 
absorptive capacity as well as the overall surface area. Several studies have been conducted 
to investigate the intestinal permeability of malnourished children with or without diarrhea as 
well as before and after nutritional rehabilitation [26-28, 39, 40, 71, 79]. The damaged villi lead 
to a compromised intestinal wall that can be associated with absorption of large 
macromolecules that lead to immune- and inflammatory diseases. These diseases further 
damage the epithelial wall and reduce the barrier for absorption of drugs. Chronic intermittent 
diarrhea may be linked to carbohydrate malabsorption within the intestine due to the rapid 
intestinal transit times associated with diarrhea that may limit overall absorption in addition to 
the differences in the permeability across the membrane [76]. Brewster et al. showed that the 
combination of increased lactulose permeation and decreased L-rhamnose absorption results 
in a higher prevalence of diarrhea [71]. Behrens et al. found repeatedly increased intestinal 
permeability to disaccharides in a number of tests on 68 Gambian infants (aged 0-18 months), 
most of whom had at least one episode of diarrhea [40]. These findings lead to the conclusion 
that diarrhea is associated with mucosal damage, which results in compromised small 
intestinal barrier function and uptake of larger molecules, such as lactulose, through the site 
of damage [73]. Therefore, diarrhea seems to correlate with abnormally high L/R – ratios and 
thus with an increased intestinal permeability. Indeed, L/R - ratios of patients with diarrhea 
were observed to be above normal in several studies and correlated with the duration and 
frequency of diarrheic events and returned to normal with resolution of diarrhea [26, 40, 71]. 
It can be stated that malnutrition itself is associated with changes in the intestinal mucosa 
resulting in a reduced absorptive area and malabsorption, while diarrhea, which is often linked 
to malnutrition, is associated with mucosal damage.  
Estimates of the prevalence of impaired intestinal permeability (higher values of L:M) range 
from 62 – 96 % that results in poor growth among infants and young children in developing 
countries in sub-Saharan Africa and Asia (urinary L:M concentration ratio > 0.10–0.12) [36, 
74, 80]. Perturbed intestinal function is associated with the malabsorption of macro- and 
micronutrients, including fat, carbohydrates, and vitamins A, B12 and folate [81-83]. Wessells 
et al. (2013) study looked at zinc absorption in Burkinabe children (6-23 months) and also 
measured the lactulose/mannitol measures to assess intestinal integrity. The results showed 
that the absorption of zinc was linked to the L:M permeability test with a greater proportion of 
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normal children showing higher levels of zinc absorption, however this was only significant 
different for the most severely affected children [29].  
3.3.4 Intestinal transit time 
The transit time through the small intestine is an important factor regarding the absorption of 
nutrients and drug products, as it affects the time that food and drugs have contact with the 
absorptive epithelium. In 1999 there was one study conducted regarding orocecal transit time 
in malnourished children. Myo-Khin et al. [37] used the lactulose breath hydrogen test to 
investigate orocecal transit in 90 Myanmar children between the ages of 1 and 5 years. After 
classification according to weight-for-age, length-for-age and weight-for-length indices, 31 
children were defined to be malnourished, whose orocecal transit time was compared to transit 
time in well-nourished children. No significant difference between malnourished and well-
nourished children was found. However, children with a history of diarrhoea were excluded 
from the study. As diarrhea and vomiting are two of the most common problems of PEM, as 
subsequent symptoms, a reduced retention of drugs and decrease of the transit time through 
the bowel can be expected [13]. 
 
3.4 Colon 
No literature was identified that reported colonic transit time and colonic permeability in 
malnourished subjects. There are some studies suggesting that malnutrition is a risk factor for 
an increased incidence or duration of diarrhea [84-87]. As a consequence of diarrhea, colonic 
transit time in malnourished children might be shorter than in healthy children. However, some 
of the currently available reports on this topic are contradictive and the information available 
to date is not sufficient for a final conclusion. Another important point to consider in this 
discussion would be the alterations in the gut microbiome that are reported for severely 
malnourished children [88]. Future research should thus focus on expanding the knowledge 
in this field. 
 
4 Discussion 
Malnutrition can affect the gastrointestinal tract and subsequently, modify drug absorption. 
Therefore, malnutrition can have an indirect impact on drug toxicity or suboptimal therapeutic 
effects. Clearly, there is a pressing need to understand the impact of malnutrition in drug 
absorption. 
The table below summarizes the findings from the literature and provides some implications 
for drug absorption in malnourished children. 
 
TABLE 5 HERE PLEASE 
 
The data identified within this search was generally quite old. Some general trends towards 
alterations in oral, gastric and small intestinal physiology were identified. Next to no 
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information on the colon, another vital section of the GI tract, was available. There is very 
limited novel data available to really understand the implications of malnutrition on the 
absorption of orally administered medicines, yet this can be of great importance for such a 
vulnerable population. A systematic review on the impact of malnutrition on the 
pharmacokinetics of drugs used in children reported that the extent of absorption was 
increased in 8 drugs, yet this was attributed to be likely due to changes in clearance rather 
than the GI physiological changes [14]. However, these statements should be handled with 
care, since these 8 drugs had significantly different properties with regard to molecular weight, 
aqueous solubility and permeability in adults and represented candidates from all classes of 
the biopharmaceutics classification system (BCS). Consequently, at least for some of these 
APIs plasma levels in malnourished children are likely to be affected by GI physiology. 
Moreover, for several other compounds, examples where absorption in malnourished children 
was unchanged or reduced can be found in the literature [15-18]. 
Current in vitro tools that are used to predict oral drug absorption are based on adult 
physiologies and Western populations. The simulated gastrointestinal media and biorelevant 
dissolution methods available to date address GI conditions in fasted and fed healthy 
European subjects [89-93]. Biorelevant in vitro tools addressing the particular GI features in 
malnourished children are currently unavailable. Therefore, there is a real need to develop 
biorelevant in vitro methods that reflect the conditions found in malnourished children and 
different types of malnutrition to better understand how drugs are absorbed in these critical 
and vulnerable populations. This will ensure the selection of adequate doses ensuring a safe 
and effective drug treatment of these children. 
Biorelevant in silico tools using physiologically based pharmacokinetic modelling can provide 
a tool to better understand the disposition of drugs within a range of populations. There has 
been some work looking at simulating a malnourished population to explore drug 
pharmacokinetics [94]. In silico tools permit exploration of predicted pharmacokinetics when 
considering each different aspect of GI physiology/anatomy for the population under 
investigation which can provide details on sensitivity to change based on the type of drug 
presented. Further work is required in this area. 
 
5 Conclusions 
Despite the significance of malnutrition as a global health issue this population has been 
neglected when considering efficacy of medicines used to treat malnourished children. Oral 
drug treatment during the acute phase of malnutrition needs to be carefully considered to 
ensure that the therapy is efficacious. Further work is required to develop biorelevant models 
that incorporate the findings from this review and to verify these in vitro and in silico models 
using appropriate pharmacokinetic data. All methods need to acknowledge the heterogeneity 
of malnutrition as a disease state as well as the age-related changes associated with 
paediatric populations. 
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